NewsRoom

(English) Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally Leads Biolabs and […]

(English) Chime Biologics Celebrates 10-Year Anniversary – New Journey, Go Beyond

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Celebrates 10-Year Anniversary – New Journey, Go Beyond May 19th, 2023, Wuhan –– Chime Biologics, a leading contract development […]

(English) Chime Biologics Appoints Vice President of Manufacturing

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics and Lepu Biopharma Celebrate Successful Consecutive Commercial Productions of Pucotenlimab

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Announced $17.4 Million Funding from Panacea Venture to Boost Its Rapid Growth

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Wins “TOP CDMO IN APAC 2022”

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Listed in “China’s Future Unicorn Enterprises in 2022”

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Establishes the European Business Center in Germany to Expand CDMO Service into European Market

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Won The Best Biologics CMO in Greater China Region

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Relisted in the Hurun Global Gazelle Index 2022 Half-Year Report

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

categoryidArraymk-test